Stem Cell Umbilical Cord Blood Market Size and Trends

The stem cell umbilical cord blood (UCB) market size is forecast to increase by USD 1.7 billion at a CAGR of 18.5% between 2023 and 2028.  The market is experiencing significant growth due to the rising prevalence of several chronic disorders, including cancer and genetic disorders. The increasing investments in the field of regenerative medicines, driven by advancements in technology and researchin healthcare system, are further fueling market growth. However, high operational costs associated with UCB collection, processing, and storage remain a challenge for market participants. Despite these challenges, the market is expected to continue its growth trajectory, driven by the potential of UCB as a valuable source of stem cells for various therapeutic applications.

 Request Free Sample

Umbilical cord blood (UCB) is a rich source of hematopoietic stem cells, which have the unique ability to develop into various blood cells. The UCB market is witnessing significant growth due to its potential applications in the treatment of chronic diseases, genetic diseases, and rare diseases, including blood illnesses such as leukemia and lymphoma. Stem cell research has led to new clinical applications, the commercialization of UCB-derived therapies, and the establishment of private UCB banks. Isolation methods and storage methods are crucial factors in the UCB market. Hematopoietic stem cells are isolated from the UCB using various techniques, while storage methods ensure the preservation of their biological activities for future use. The placenta and newborn baby's cord tissue also contain adult stem cells with regenerative properties, which have tissue development and therapeutic potential in regenerative medicines. The UCB market is expected to grow significantly due to the increasing prevalence of life threatening diseases and the potential of UCB in treating a wide range of conditions. The use of UCB in the treatment of hematopoietic disorders, genetic diseases, and rare diseases is a major driver of market growth. The development of new isolation and storage methods and the increasing awareness of cord blood donation are also contributing to market expansion.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user
  • Pharmaceutical
  • Research institutes
  • Hospitals
  • Biobanks
• Geography
  • North America
    • US
  • Asia
  • Europe
    • Germany
    • UK
  • Rest of World (ROW)

By End-user Insights

The pharmaceutical segment is estimated to witness significant growth during the forecast period. Stem cells, particularly those found in umbilical cord blood (UCB), hold immense potential in the field of therapeutics for various chronic, genetic, and rare diseases. These precious cells, rich in hematopoietic stem cells, can differentiate into diverse cell types, making them invaluable in the treatment of blood illnesses such as leukemia and lymphoma, as well as immune disorders, metabolic disorders, cancer, diabetes, and other life-threatening conditions.

Get a glance at the market share of various segment Download the PDF Sample

The pharmaceutical segment was the largest segment and valued at USD 444.60 million in 2018. The global market for stem cell UCB is experiencing significant growth due to the increasing clinical applications and commercialization of these cells. Pharmaceutical companies are capitalizing on the advanced healthcare infrastructure in established markets to introduce stem cell solutions. Hence, such factors are fuelling the growth of this segment during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Stem cells, specifically umbilical cord blood (UCB), have emerged as a promising solution for the treatment of various chronic and genetic diseases. Hematopoietic stem cells present in UCB hold immense potential for clinical applications, particularly in the context of rare diseases and life-threatening conditions such as cancer, diabetes, blood diseases, immune disorders, and metabolic disorders. The commercialization of UCB-derived therapeutics in regenerative medicine and transplant medicine is gaining momentum.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Stem Cell Umbilical Cord Blood Market Market Driver

Rising prevalence of several chronic disorders is notably driving market growth. Chronic diseases, including cardiovascular disease, cancer, chronic obstructive pulmonary disease, and type 2 diabetes, account for a significant portion of global morbidity and mortality. These conditions are often caused by lifestyle factors such as physical inactivity, unhealthy diet, and tobacco use.

 Clinical applications of UCB stem cells in therapeutics and transplant medicine have gained significant attention due to their potential to treat a wide range of conditions, including blood diseases, immune disorders, metabolic disorders, and cancer. Commercialization of UCB storage services has also gained momentum, with private UCB banks offering hybrid storage services that include testing and storage. Thus, such factors are driving the growth of the market during the forecast period.

Stem Cell Umbilical Cord Blood Market Market Trends

Increasing investments in field of regenerative medicines is the key trend in the market. Stem cells, particularly those found in umbilical cord blood (UCB), hold immense potential for the treatment of various chronic, genetic, and rare diseases. These include hematopoietic stem cells, which are crucial for blood development and can be used to treat blood illnesses such as leukemia and lymphoma. UCB stem cells also exhibit biological activities that can contribute to regenerative medicines for immune disorders, metabolic disorders, and even cancer.

Clinical applications of stem cells are expanding rapidly, with commercialization of therapeutics and storage services becoming increasingly common. Policies regarding stem cell research and storage vary across regions, with some countries embracing the technology and others raising ethical and cultural issues. Hospitals and clinics are integrating cord tissue storage into their services, providing hybrid storage solutions for both testing and long-term preservation.

Stem Cell Umbilical Cord Blood Market Market Challenge

High operational costs is the major challenge that affects the growth of the market. The global market is witnessing significant growth due to its potential applications in the treatment of various chronic, genetic, and rare diseases, including hematopoietic stem cell disorders, cancer, diabetes, blood diseases, immune disorders, metabolic disorders, and regenerative medicine. Clinical trials and commercialization of stem cell therapies in transplant medicine and regenerative medicines continue to expand, driving the demand for UCB.

However, the high operational costs associated with the storage and processing of these cells pose a challenge to the market's growth.  Ethical and cultural issues surrounding the use of cord blood and policies regarding its collection, testing, and storage also impact the market. Cryopreservation methods and hybrid storage services are being explored to reduce costs and improve accessibility. Hospitals and clinics play a crucial role in raising awareness about the potential benefits of UCB for the treatment of life-threatening diseases, such as leukemia and lymphoma. Hence, the above factors will impede the growth of the market during the forecast period

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Americord Registry LLC: The company offers stem cell UCB products such as Cord Blood 2.0.

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Athersys Inc.
• CBR Systems Inc.
• Cells4Life Group LLP
• Celularity Inc.
• Cordlife Group Ltd.
• CRYO-CELL International Inc
• Cryo Stemcell
• Cryoviva Biotech Pvt. Ltd.
• FamiCord Group
• FUTURE CELL Japan
• Global Cord Blood Corp.
• LifeCell International Pvt. Ltd.
• MEDIPOST Co. Ltd.
• Next Biosciences Pty Ltd.
• Regrow Biosciences Pvt Ltd.
• Smart Cells International Ltd.
• Smith and Nephew plc
• ViaCord LLC
• Vita 34 AG

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

Stem cells derived from umbilical cord blood (UCB) have gained significant attention in the medical community due to their potential therapeutic applications in treating various chronic diseases, genetic diseases, and rare conditions. Hematopoietic stem cells present in UCB have clinical applications in blood diseases, immune disorders, metabolic disorders, and cancer. The commercialization of UCB-derived stem cells is on the rise, driven by the increasing demand for therapeutics in transplant medicine and regenerative medicine. UCB storage services have become essential for preserving these valuable cells for future use. Policies and ethical issues surrounding the use of UCB for therapeutic purposes continue to evolve. Cryopreservation is a common storage method for UCB, ensuring the cells maintain their biological activities for potential use in treating lifethreatening diseases such as leukaemia and lymphoma. The market for UCB-derived stem cells is expanding, with hospitals and clinics increasingly offering cord tissue storage services for newborn babies. Private UCB banks are also gaining popularity, offering hybrid storage services for both cord tissue and blood. The potential therapeutic applications for UCB in treating blood illnesses, diabetes, and other metabolic disorders continue to drive the growth of this market. Despite the advancements in UCB-derived stem cell research and commercialization, cultural and ethical issues surrounding their use remain a concern. Continued awareness and education are necessary to ensure the safe and ethical use of these valuable cells in the treatment of various diseases.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2023 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Asia, Europe, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch